AllQuantitative Report
logoArgusFebruary 17, 2021

JAZZ: Lowering target price to $175.00

Symbols
JAZZ
Sector(s)
Healthcare
Rating
Current Price
$168.90
Price Target
$NaN
Earnings Estimate
Summary

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and indications in neuroscience and hematology-oncology.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free